In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Electrocore (ECOR – Research Report), with a price target of $1.50. The company's shares closed last Friday at $0.60. According to TipRanks.com, Vendetti is a 4-star analyst with an average return of 3.8% and a 36.3% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Guardion Health Sciences, Applied DNA Sciences, and Dermata Therapeutics. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Electrocore with a $1.50 average price target. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $1.
https://www.tipranks.com/news/blurbs/maxim-group-maintains-their-buy-rating-on-electrocore-ecor?utm_source=advfn.com&utm_medium=referral
electroCore (NASDAQ:ECOR)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more electroCore Charts.
electroCore (NASDAQ:ECOR)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more electroCore Charts.